151 related articles for article (PubMed ID: 30761009)
1. A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
Schneider MP; Achtari Jeanneret L; Chevaux B; Backes C; Wagner AD; Bugnon O; Luthi F; Locatelli I
Front Pharmacol; 2018; 9():1567. PubMed ID: 30761009
[No Abstract] [Full Text] [Related]
2. Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.
Bandiera C; Cardoso E; Locatelli I; Digklia A; Zaman K; Diciolla A; Cristina V; Stravodimou A; Veronica AL; Dolcan A; Sarivalasis A; Liapi A; Bouchaab H; Orcurto A; Dotta-Celio J; Peters S; Decosterd L; Widmer N; Wagner D; Csajka C; Schneider MP
JMIR Res Protoc; 2021 Jun; 10(6):e30090. PubMed ID: 34185020
[TBL] [Abstract][Full Text] [Related]
3. Enhancing patients' understanding of and adherence to oral anticancer medication: Results of a longitudinal pilot intervention.
Lin M; Hackenyos D; Savidge N; Weidner RA; Murphy-Banks R; Fleckner T; Parsons SK; Rodday AM
J Oncol Pharm Pract; 2021 Sep; 27(6):1409-1421. PubMed ID: 32996363
[TBL] [Abstract][Full Text] [Related]
4. ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.
Belcher SM; Mackler E; Muluneh B; Ginex PK; Anderson MK; Bettencourt E; DasGupta RK; Elliott J; Hall E; Karlin M; Kostoff D; Marshall VK; Millisor VE; Molnar M; Schneider SM; Tipton J; Yackzan S; LeFebvre KB; Sivakumaran K; Waseem H; Morgan RL
Oncol Nurs Forum; 2022 Jun; 49(4):279-295. PubMed ID: 35788731
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
.
Atkinson TM; Rodríguez VM; Gordon M; Avildsen IK; Emanu JC; Jewell ST; Anselmi KA; Ginex PK
Oncol Nurs Forum; 2016 Sep; 43(5):576-82. PubMed ID: 27541550
[TBL] [Abstract][Full Text] [Related]
6. Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS).
Bandiera C; Dotta-Celio J; Locatelli I; Nobre D; Wuerzner G; Pruijm M; Lamine F; Burnier M; Zanchi A; Schneider MP
JMIR Res Protoc; 2021 Mar; 10(3):e25966. PubMed ID: 33739292
[TBL] [Abstract][Full Text] [Related]
7. Assessment of patients' understanding of and adherence to oral anticancer medication (OAM): Results of a cross-sectional institutional pilot study.
Rodday AM; Hackenyos D; Masood R; Savidge N; Lin M; Weidner RA; Parsons SK
J Oncol Pharm Pract; 2021 Oct; 27(7):1569-1577. PubMed ID: 33019872
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Oral Anticancer Medications After Implementation of an Ambulatory Adherence Program at a Large Urban Academic Hospital.
Curry MA; Chineke I; Redelico T; Terrell C; Bell W; Flood D; Mishra P; LaFollette J; Power S; Bernal-Mizrachi L
JCO Oncol Pract; 2020 Apr; 16(4):e350-e356. PubMed ID: 32048938
[TBL] [Abstract][Full Text] [Related]
9. Patient adherence to rivaroxaban in deep vein thrombosis, a cohort study in Switzerland: quantitative results.
Dotta-Celio J; Alatri A; Locatelli I; Salvi M; Bugnon O; Schneider MP; Mazzolai L
Int J Clin Pharm; 2019 Dec; 41(6):1625-1633. PubMed ID: 31776778
[TBL] [Abstract][Full Text] [Related]
10. Why individual-level interventions are not enough: Systems-level determinants of oral anticancer medication adherence.
Dean LT; George M; Lee KT; Ashing K
Cancer; 2020 Aug; 126(16):3606-3612. PubMed ID: 32438466
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.
Lin C; Clark R; Tu P; Bosworth HB; Zullig LL
Breast Cancer Res Treat; 2017 Sep; 165(2):247-260. PubMed ID: 28573448
[TBL] [Abstract][Full Text] [Related]
12. Domains of Structured Oral Anticancer Medication Programs: A Scoping Review.
Sivakumaran K; Ginex PK; Waseem H; Belcher SM; Lagler-Clark S; LeFebvre KB; Palmer N; Pasumarthi T; Morgan RL
Oncol Nurs Forum; 2022 Jun; 49(4):296-306. PubMed ID: 35788732
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Provider Adherence to Recommended Monitoring Parameters for Oral Anticancer Medications.
Redelico TJ; Walton SM; LaFollette J; Adams Curry M; Bernal-Mizrachi L
J Oncol Pract; 2018 Jul; 14(7):e446-e450. PubMed ID: 29813011
[TBL] [Abstract][Full Text] [Related]
14. Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study.
Onwusah DO; Ojewole EB; Manyangadze T; Chimbari MJ
Patient Prefer Adherence; 2023; 17():2821-2839. PubMed ID: 37953981
[TBL] [Abstract][Full Text] [Related]
15. Patient-centered design in developing a mobile application for oral anticancer medications.
Crawford SY; Boyd AD; Nayak AK; Venepalli NK; Cuellar S; Wirth SM; Hsu GI
J Am Pharm Assoc (2003); 2019; 59(2S):S86-S95.e1. PubMed ID: 30745188
[TBL] [Abstract][Full Text] [Related]
16. Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists' and Patients' Perspectives.
Ali EE; Chan SSL; Poh HY; Susanto YA; Suganya T; Leow JL; Pang CK; Chew L; Yap KY
J Med Syst; 2019 Feb; 43(3):63. PubMed ID: 30726518
[TBL] [Abstract][Full Text] [Related]
17. A community-based advanced nurse practitioner-led integrated oncology care model for adults receiving oral anticancer medication: a pilot study.
Richmond JP; Kelly MG; Johnston A; Murphy PJ; O'Connor L; Gillespie P; Hobbins A; Alvarez-Iglesias A; Murphy AW
Pilot Feasibility Stud; 2024 Feb; 10(1):46. PubMed ID: 38424625
[TBL] [Abstract][Full Text] [Related]
18. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study.
Misdrahi D; Tessier A; Husky M; Lange AC; Vrijens B; Llorca PM; Baylé FJ
Schizophr Res; 2018 Mar; 193():114-118. PubMed ID: 28663027
[TBL] [Abstract][Full Text] [Related]
20. Estimation of adherence to medication treatment in presence of censoring.
Pasquier J; Schneider MP; Locatelli I
Br J Clin Pharmacol; 2023 Jul; 89(7):1928-1937. PubMed ID: 35776776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
